Implementation of Clinical Pathway to Improve Quality of Healthcare in Stroke Inpatients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02978794

Enrollment

300

Registered

2016-12-01

Start date

2016-11-30

Completion date

2022-02-28

Last updated

2021-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, clinical pathway, medical care

Brief summary

With the extension of the average life expectancy, the incidence of cardiovascular diseases is also rising. Stroke in Taiwan has been the leading cause of morbidity and mortality, but also in countries around the world), stroke and the impact of socio-economic and health spending are large how to reduce the degree of disability after stroke is an important issue in medicine. For a long time, the resident will fill the clinical pathway form before the stroke inpatients were discharged. We also analyzed the data of clinical pathway every three months. According to the current data of stroke clinical pathway included demographic data, length of hospitalization days, complications, functional independent measure, Brunnstrom motor recovery stage, mini-mental state examination, geriatric depression scale, blood pressure data, and post-stroke checklist for a retrospective analysis to provide more complete and more comprehensive information on follow-up care for stroke patients and effective use of medical resources, to improve the quality of future medical care and quality of life for stroke patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 85 Years

Healthy volunteers

Inclusion criteria

1. Ischemic and hemorrhagic stroke patients 2. MRI confirmed the diagnosis of stroke 3. Within three months of onset of unilateral limb hemiplegia in patients

Exclusion criteria

1. Initial tracheostomy impantation and hospital stay is less than 5 days 2. Combined with other neurological diseases, such as epilepsy, multiple neuropathy, Meniere's disease, vestibular neuritis, Parkinson's disease, dementia or cerebellar atrophy, etc. 3. Significant lesions of the lower limb joints, including joint contractures, lower limb fractures, joint replacement or long-term pain in patients with osteoarthritis 4. Unstable signs of life (if not through the tilt bed test) or severe cardiopulmonary disease 5. Those who can not cooperate with the study or who have not signed the inform consent

Design outcomes

Primary

Measure	Time frame
functional independent measurement	1 year
post-stroke checklist	1 year
Brunnstrom motor recovery stage	1 year

Outcome results